Search results
Author(s):
Joris van den Hurk
Added:
3 years ago
Cardiovascular disease (CVD) is the most common cause of death worldwide.1 With an estimated 7.6 million global deaths due to coronary heart disease in 2005,2 the size of the burden placed on society cannot be understated. Acute myocardial infarction (AMI), the classic ‘heart attack,’ will be the classification given to many of these deaths. In its most life-threatening form, AMI is identified…
View more
Author(s):
Derek P Chew
,
Harvey D White
Added:
3 years ago
Effective translation of reperfusion therapy to mortality reductions in ST-segment elevation myocardial infarction (STEMI) remains both time-critical in its implementation and dependent on optimal antithrombotic therapy. Innumerable clinical studies have explored several antithrombin and antiplatelet therapies in the immediate management of STEMI. With the wide array of the therapies now…
View more
Author(s):
Binita Shah
Added:
4 years ago
Dr Binita Shah (NYU Langone Health, New York, NY, US) discusses Colchicine in Percutaneous Coronary Intervention (PCI).
Questions:
1.What is colchicine and why study it in PCI?
2.What was the study design, patient population and primary and secondary outcomes?
3.What were your outcomes?
4.How do these compare to those in the COLCOT study?
5.How should your study be interpreted in clinical…
View more
PCI for Chronic Total Occlusion
Author(s):
Giovanni Maria Vescovo
,
Carlo Zivelonghi
,
Benjamin Scott
,
et al
Added:
3 years ago
Article
Author(s):
Gregory J Dehmer
Added:
3 years ago
The use of percutaneous coronary intervention (PCI) for coronary artery revascularization has grown considerably since the first balloon angioplasty in 1977. Improvements in equipment and drug therapies plus the development of coronary artery stents have all contributed to the growth of PCI as an alternative to surgical revascularization. Compared with the early days of balloon angioplasty, when…
View more
Author(s):
Rhian E Davies
,
J Dawn Abbott
Added:
3 years ago
Percutaneous Coronary Intervention for Clinical Syndromes
Stable Angina
The primary benefit of percutaneous coronary intervention (PCI) over medical therapy in patients with stable angina is the improved quality of life. The PCI in stable angina (ORBITA) trial was the first sham-controlled trial of PCI where 200 medically optimized patients with single vessel disease were randomized to PCI or…
View more
Author(s):
Ahmed M Alabbady
,
Ahmed S Abdul-Al
,
Kimberly A Skelding
Added:
3 years ago
The introduction of percutaneous coronary angioplasty in 1977 by Dr Andreas Grüntzig1 was one of the most remarkable achievements in the cardiology realm, opening the door to numerous advancements in percutaneous coronary interventions (PCIs). Due to advances in PCI techniques over the past four decades, catheters along with four generations of coronary stents have dramatically changed the…
View more
Author(s):
Arjun K Ghosh
,
Deepak L Bhatt
,
Cezar Iliescu
Added:
2 years ago
Cardio-oncology topic editor, Dr Arjun Ghosh (University College London Hospital and Hatter Cardiovascular Institute, UK) is joined by Dr. Deepak L. Bhatt (Brigham and Women's Hospital, Medical School, US) and Dr Cezar Iliescu(The University of Texas MD Anderson Cancer Center, US) to discuss interventional issues in cancer patients with a focus on patients with acute coronary syndromes (ACS)…
View more
Author(s):
Duk-Woo Park
,
Do-Yoon Kang
Added:
6 months ago
ESC 2023 — We are joined onsite by Dr Duk-Woo Park and Dr Do-Yoon Kang (Asan Medical Center, Seoul, KR) to discuss the findings from the OCTIVUS study (NCT03394079).
The OCTIVUS study (Seung-Jung Park, CardioVascular Research Foundation, Korea) aims to compare the clinical safety and efficacy of optimal coherence tomography (OCT) guided and intravascular ultrasound (IVUS) guided strategies in…
View more
Author(s):
Alexander G Truesdell
,
Rhian E Davies
,
Moemen Eltelbany
,
et al
Added:
11 months ago